{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:43:26Z","timestamp":1785786206792,"version":"3.56.0"},"reference-count":44,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Florida Office of the State Courts Administrator"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Background: Criminal problem-solving courts and civil dependency courts often have participants with substance use disorder (SUD), including opioid use disorder (OUD). These courts refer participants to treatment and set treatment-related requirements for court participants to avoid incarceration or to regain custody of children. Medications for opioid use disorder (MOUD) are the most effective treatment for OUD but are underutilized by court system participants. Little is known about variation in court policies for different MOUDs. Also, more information is needed about types of policies for each MOUD, including whether participants may begin MOUD, continue previously begun MOUD, or complete the court program with MOUD. Methods: An online survey was distributed to criminal problem-solving and civil dependency judges in Florida in 2019 and 2020, yielding data from 58 judges (a 24% response rate). We used nonparametric statistics to test hypotheses with ordinal data. A Friedman's test for related samples or Cochran's Q was used to make within-group comparisons between policies and MOUDs. Results: We found considerable policy variation, with more permissive policies for naltrexone than buprenorphine or methadone, and more permissive policies for continuing MOUD than for initiating MOUD or completing a court program with MOUD. For each medication, less than one quarter of judges indicated their court always permits MOUD, with most indicating that MOUD is permitted sometimes or usually. Conclusion: Because respondents rarely chose \u201cnever\u201d or \u201calways\u201d for any MOUD policy, most courts appear to be making MOUD decisions on a case-by-case basis. A clearer understanding of this decision-making process is needed. Some court participants may be required to discontinue MOUD before completing a court program, even if they were permitted to start or continue MOUD treatment. Discontinuation of MOUD without medical justification is contrary to the standard of care for individuals with OUD and increases their risk of overdose.<\/jats:p>","DOI":"10.1080\/08897077.2021.1944958","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T11:06:32Z","timestamp":1625742392000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Criminal Problem-Solving and Civil Dependency Court Policies regarding Medications for Opioid use Disorder"],"prefix":"10.1177","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6369","authenticated-orcid":false,"given":"Barbara","family":"Andraka-Christou","sequence":"first","affiliation":[{"name":"Department of Health Management and Informatics, University of Central Florida, Orlando, FL, USA"},{"name":"Department of Internal Medicine (Joint Secondary Appointment), University of Central Florida, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MH","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Learning Sciences and Educational Research, University of Central Florida, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Health Management and Informatics, University of Central Florida, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6481-2196","authenticated-orcid":false,"given":"Brandon","family":"del Pozo","sequence":"additional","affiliation":[{"name":"Warren Alpert Medical School, Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2021.1944958","volume-title":"Veterans Treatment Courts: Studying Dissemination, Implementation, and Impact of Treatment-Oriented Criminal Courts","author":"Baldwin J.","year":"2013"},{"key":"bibr2-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201600233"},{"key":"bibr3-08897077.2021.1944958","volume-title":". Painting the Current Picture: A National Report on Drug Courts and Other Problem-Solving Courts in the United States","author":"Douglas Marlowe CH","year":"2016"},{"key":"bibr4-08897077.2021.1944958","unstructured":"Center for Children and Family Futures and National Association of Drug Court Professionals. Family Treatment Court Best Practice Standards. Center for Children and Family Futures and National Association of Drug Court Professionals; 2019. Supported by Grant #2016-DC-BX-K003 awarded by the Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U.S. Department of Justice, Lake Forest, CA."},{"key":"bibr5-08897077.2021.1944958","volume-title":"Mental Health Courts: A Guide to Research-Informed Policy and Practice","author":"Dodd EA.","year":"2009"},{"key":"bibr6-08897077.2021.1944958","unstructured":"National Academies of Science Engineering & Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press; 2019."},{"key":"bibr7-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"bibr8-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"bibr9-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2013.74.605"},{"issue":"5","key":"bibr10-08897077.2021.1944958","first-page":"CD011117","author":"Nielsen S","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr11-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.0890"},{"key":"bibr12-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1177\/1178221820953390"},{"key":"bibr13-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1080\/10509674.2019.1582573"},{"key":"bibr14-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.611460"},{"key":"bibr15-08897077.2021.1944958","unstructured":"Physicians for Human Rights. Neither Justice nor Treatment: Drug Courts in the United States. New York, NY: Physicians for Human Rights; 2017."},{"key":"bibr16-08897077.2021.1944958","author":"National Association of Drug Court Professionals","year":"2015","journal-title":"Adult Drug Court Best Practice Standards Volume II National Association of Drug Court Professionals"},{"key":"bibr17-08897077.2021.1944958","first-page":"1","author":"Andraka-Christou B","year":"2020","journal-title":"Subst Abus"},{"key":"bibr18-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.10.004"},{"key":"bibr19-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-10-35"},{"key":"bibr20-08897077.2021.1944958","first-page":"189","volume":"13","author":"Andraka-Christou B.","year":"2017","journal-title":"CRCL"},{"key":"bibr21-08897077.2021.1944958","unstructured":"U.S. Bureau of Justice Assistance. Medication-assisted Treatment. https:\/\/bja.ojp.gov\/sites\/g\/files\/xyckuh186\/files\/media\/document\/adc-faq-medication-assisted-treatment.pdf"},{"key":"bibr22-08897077.2021.1944958","unstructured":"Substance Abuse and Mental Health Services Administration. Grants to Expand Substance Abuse Treatment Capacity in Adult and Family Treatment Drug Courts: Funding Opportunity Announcement (FOA) No. TI-20-003. Rockville, MD: Substance Abuse & Mental Health Services Administration; 2020."},{"key":"bibr23-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2020.1807559"},{"key":"bibr24-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.06.011"},{"key":"bibr25-08897077.2021.1944958","unstructured":"Smith v. Aroostook, No. 1:18-cv-352-NT (D. Me. Mar. 27, 2019)."},{"key":"bibr26-08897077.2021.1944958","unstructured":"Smith v. Aroostook, No. 1:18 cv 352 NT (D. Me. Mar. 27, 2019), aff'd, No. 19 1340, (1st Cir. Apr. 30)."},{"key":"bibr27-08897077.2021.1944958","unstructured":"Qualtrics Experience Management Platform\n                      [computer program]. Version 1.3. Provo, Utah; 2018."},{"key":"bibr28-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.07.001"},{"key":"bibr29-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17070732"},{"key":"bibr30-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655"},{"key":"bibr31-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13090"},{"key":"bibr32-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1177\/0193841X13487536"},{"key":"bibr33-08897077.2021.1944958","unstructured":"Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Full Document. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018."},{"key":"bibr34-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701860971"},{"key":"bibr35-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4647"},{"key":"bibr36-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1111\/add.13270"},{"key":"bibr37-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.009"},{"key":"bibr38-08897077.2021.1944958","unstructured":"National Association of Drug Court Professionals. Adult Drug Court Best Practice Standards Volume I Text Revision. Alexandria, VA: National Association of Drug Court Professionals; 2018."},{"key":"bibr39-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-0252-z"},{"key":"bibr40-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.06.012"},{"key":"bibr41-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.4614"},{"key":"bibr42-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1129389"},{"key":"bibr43-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0024"},{"key":"bibr44-08897077.2021.1944958","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.10.001"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1944958","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1944958","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1944958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:24Z","timestamp":1777625724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1944958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2021.1944958"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1944958","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}